1 Item 1A. Risk Factors 25 Item 1B. Unresolved Staff Comments 62 Item 1C. Cybersecurity 62 Item 2. Properties 63 Item 3. Legal Proceedings 63 Item 4. Mine Safety Disclosures 63 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 64 Item 6. Not applicable 64 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 65 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 72 Ite...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126278 | EDGAR | 83K words |
| 2025-02-14 | 2024-12-31 | 0000950170-25-020467 | EDGAR | — |
| 2024-03-05 | 2023-12-31 | 0000950170-24-025428 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0000950170-23-010757 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001564590-22-011575 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001564590-21-016875 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001564590-20-012791 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001564590-19-008184 | EDGAR | — |
| 2018-03-13 | 2017-12-31 | 0001564590-18-005384 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001564590-17-005738 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269598 | EDGAR | 44K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106247 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072622 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122837 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093366 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055096 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063379 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-040983 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-020870 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001564590-22-037287 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001564590-22-029025 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001564590-22-019685 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001193125-26-126190 | EDGAR | 3K words |
| 2026-03-11 | 0001193125-26-100539 | EDGAR | — |
| 2026-02-19 | 0001193125-26-057707 | EDGAR | — |
| 2026-02-03 | 0001193125-26-034473 | EDGAR | — |
| 2026-01-09 | 0001193125-26-008318 | EDGAR | — |
| 2025-12-29 | 0001193125-25-335497 | EDGAR | — |
| 2025-12-09 | 0001193125-25-312972 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269470 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258665 | EDGAR | — |
| 2025-09-16 | 0001193125-25-205107 | EDGAR | — |
247 total filings indexed. 215 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001671584 |
| Ticker | APVO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aptevotherapeutics.com |
| Listed | 2016-07-20 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report